STERIMED acquired by IK PARTNERS
Context
Sterimed completes its third buy-out (LBO) as IK Partners returns as the majority shareholder, taking over from Sagard. This transaction values the group at over EUR1 billion, a significant jump from its previous valuation. Under Sagard's ownership, Sterimed accelerated its international expansion, notably in North America and Asia. The new partnership with IK Partners aims to further consolidate the medical packaging market through a global buy-and-build strategy and to invest in sustainable, eco-friendly sterilization solutions.
It is worth noting that the fund Sagard took control of Sterimed through an LBO in 2019.
STERIMED, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
A global leader in the manufacturing of medical sterilization packaging solutions. Sterimed designs, produces, and markets high-performance packaging materials (paper, film, and complex materials) used by medical device manufacturers and hospitals to maintain the sterility of instruments. The group operates several production sites worldwide (France, China, USA, Mexico).
Ent. Value
€500M–1.5bn
Equity Value
[members only]
Multiples
EV / Revenue
1x–3x
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with STERIMED
Other operations with STERIMED
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 05/2025 | IK PARTNERS | BIOBANK | FRANCE | Implants & Prosthetics |
| 05/2025 | OTTOBOCK | MATTON ORTHOMEDI | BELGIUM | Implants & Prosthetics |
| 04/2025 | CINVEN | NUTRISENS | FRANCE | Nutrition & Dietary Supplements |
| 04/2025 | NORGINE | THERAVIA | FRANCE | Generics / Labs |
| 04/2025 | PATIENT SQUARE CAPITAL | PATTERSON COMPANIES | UNITED STATES | Medical Consumables |
| 04/2025 | INSTITUT MERIEUX / ARCHIMED | CEVA SANTE ANIMALE | FRANCE | Animal Health |
| 04/2025 | Knop Investments | AVANCE CARE GROUP | NETHERLANDS | Medical Devices |
| 03/2025 | LBO FRANCE | HEMODIA | FRANCE | Medical Devices |
| 03/2025 | NUTRISENS | PRODIET | BRAZIL | Nutrition & Dietary Supplements |
| 03/2025 | SIPAREX | LABORATOIRE POLIDIS | FRANCE | Medical Consumables |
Other operations with IK PARTNERS
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2026 | IK PARTNERS | SELATEK | SWEDEN | Electrical |
| 03/2026 | IK PARTNERS | DOMEK GROUP | NETHERLANDS | Brokerage |
| 12/2025 | IK PARTNERS | RHETORES | FRANCE | Wealth & Asset Management |
| 12/2025 | IK PARTNERS | ASCORA | FRANCE | Brokerage |
| 11/2025 | IK PARTNERS | ENDRIX (EX SFC) | FRANCE | Accounting & Audit |
| 08/2025 | IK PARTNERS | Francks Kylindustri | SWEDEN | HVAC (Heating/AC) |
| 05/2025 | IK PARTNERS | DATAPART Factoring | GERMANY | Factoring |
| 05/2025 | IK PARTNERS | Kestrel Capital | IRELAND | Wealth & Asset Management |
| 05/2025 | IK PARTNERS | BIOBANK | FRANCE | Implants & Prosthetics |
| 05/2025 | IK PARTNERS | Lohoff Pension Services | GERMANY | ERP, HR & Finance |
REFERENCES
Valuation range: EV €500M–1.5bn
Revenue range: €250–500M
EV/Revenue range: 1x - 3x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of STERIMED by IK PARTNERS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: sterimed
Acquirer: ik partners